Literature DB >> 4259338

Degradation of heparin in mouse mastocytoma tissue.

S Ogren, U Lindahl.   

Abstract

1. Heparin was prepared from mouse mastocytoma tissue by mild procedures, including extraction of mast-cell granules with 2m-potassium chloride, precipitation of the extracted polysaccharide with cetylpyridinium chloride from 0.8m-potassium chloride and finally digestion of the isolated material with testicular hyaluronidase. The resulting product (fraction GE(H)) represented approx. 40% of the total heparin content of the tissue. 2. Fraction GE(H) was fractionated by gel chromatography on Sepharose 4B into three subfractions, with average molecular weights ( M(w)) of approx. 60000-70000 (highly polydisperse material), 26000 and 9000 respectively. Treatment of each of the subfractions with alkali or with papain did not affect their behaviour on gel chromatography. Amino acid and neutral sugar analyses indicated that the two low-molecular-weight fractions consisted largely of single polysaccharide chains lacking the carbohydrate-protein linkage region. It was suggested that these heparin molecules had been degraded by an endopolysaccharidase. 3. Pulse labelling in vivo of mastocytoma heparin with [(35)S]sulphate showed initial labelling of large molecules followed by a progressive shift of radioactivity toward fractions of lower molecular weight. Further, heparin-depolymerizing activity was demonstrated by incubating (35)S-labelled heparin in vitro with a mastocytoma 10000g-supernatant fraction. Appreciable degradation of the polysaccharide occurred, as demonstrated by gel chromatography. In contrast, no depolymerization was observed on subjecting (14)C-labelled chondroitin sulphate to the same procedure.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4259338      PMCID: PMC1178276          DOI: 10.1042/bj1251119

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Catabolism of mucopolysaccharides by rat liver lysosomes in vivo.

Authors:  N N Aronson; E A Davidson
Journal:  J Biol Chem       Date:  1968-09-10       Impact factor: 5.157

2.  The enzymatic degradation of heparin and heparitin sulfate. I. The fractionation of a crude heparinase from flavobacteria.

Authors:  A Linker; P Hovingh
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

3.  Comment on the use of cetylpyridinium chloride in the isolation of connective-tissue proteoglycan.

Authors:  U Lindahl
Journal:  Biochem J       Date:  1969-07       Impact factor: 3.857

4.  [Catabolic mucopolysaccharide protein metabolism in human organs].

Authors:  D Platt; U Stein
Journal:  Z Klin Chem Klin Biochem       Date:  1969-07

5.  Purification and properties of bacterial chondroitinases and chondrosulfatases.

Authors:  T Yamagata; H Saito; O Habuchi; S Suzuki
Journal:  J Biol Chem       Date:  1968-04-10       Impact factor: 5.157

6.  Analytical and preparative separation of acidic glycosaminoglycans by electrophoresis in barium acetate.

Authors:  E Wessler
Journal:  Anal Biochem       Date:  1968-12       Impact factor: 3.365

7.  Enzymic degradation of heparin. A glucosaminidase and a glycuronidase from Flavobacterium heparinum.

Authors:  C P Dietrich
Journal:  Biochemistry       Date:  1969-05       Impact factor: 3.162

8.  Further characterization of the heparin-protein linkage region.

Authors:  U Lindahl
Journal:  Biochim Biophys Acta       Date:  1966-12-28

9.  Evidence for the existence of a multichain proteoglycan of heparan sulphate.

Authors:  L Jansson; U Lindahl
Journal:  Biochem J       Date:  1970-05       Impact factor: 3.857

10.  Attempted isolation of a heparin proteoglycan from bovine liver capsule.

Authors:  U Lindahl
Journal:  Biochem J       Date:  1970-01       Impact factor: 3.857

View more
  14 in total

Review 1.  Mast cell proteoglycans.

Authors:  Elin Rönnberg; Fabio R Melo; Gunnar Pejler
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

2.  Biosynthesis of heparin. Solubilization and partial characterization of N- and O-sulphotransferases.

Authors:  L Jansson; M Höök; A Wasteson; U Lindahl
Journal:  Biochem J       Date:  1975-07       Impact factor: 3.857

3.  Degradation of heparin proteoglycan in cultured mouse mastocytoma cells.

Authors:  K G Jacobsson; U Lindahl
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

Review 4.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

5.  Uptake and degradation of mast-cell granules by mouse peritoneal macrophages.

Authors:  U Lindahl; H Pertoft; R Seljelid
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

6.  The assay and partial characterization of macromolecular heparin depolymerase activity in rat small intestine.

Authors:  E Young; A A Horner
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

7.  Bioengineering murine mastocytoma cells to produce anticoagulant heparin.

Authors:  Leyla Gasimli; Charles A Glass; Payel Datta; Bo Yang; Guoyun Li; Trent R Gemmill; Jong Youn Baik; Susan T Sharfstein; Jeffrey D Esko; Robert J Linhardt
Journal:  Glycobiology       Date:  2013-12-09       Impact factor: 4.313

8.  Metabolism of macromolecular heparin in mouse neoplastic mast cells.

Authors:  S Ogren; U Lindahl
Journal:  Biochem J       Date:  1976-03-15       Impact factor: 3.857

9.  Glycosaminoglycans in rat mucosal mast cells.

Authors:  L Enerbäck; S O Kolset; M Kusche; A Hjerpe; U Lindahl
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

10.  Effect of cycloheximide, beta-D-xylosides and beta-D-galactosides on heparin biosynthesis in mouse mastocytoma.

Authors:  H C Robinson; U Lindahl
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.